NDC 24979-703
Dexlansoprazole delayed release 30 mg capsule, delayed release
On the label: TWi Pharmaceuticals, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| F.i.s. Fabbrica Italiana Sintetici S.p.a. | Montecchio Maggiore, Italy | Makes the active ingredient and tests it | Problems found, fixed voluntarilyMar 6, 2026 · 7 inspections |
| Patheon Manufacturing Services LLC | Greenville, NC, United States | Makes it and tests it | No problems foundSep 26, 2025 · 11 inspections |
| Takeda GmbH | Oranienburg, Germany | Makes it and tests it | Problems found, fixed voluntarilyNov 28, 2025 · 7 inspections |
| Takeda Ireland Limited | Bray, Ireland | Makes it and tests it | Problems found, fixed voluntarilyDec 9, 2022 · 6 inspections |
| Takeda Pharmaceutical Company Limited | Yodogawa-Ku, Japan | Makes it and tests it | No problems foundApr 12, 2024 · 7 inspections |
| Takeda Pharmaceutical Company Limited | Hikari, Japan | Makes the active ingredient and tests it | Problems found, fixed voluntarilyNov 6, 2023 · 9 inspections, 1 with FDA action |
| AbbVie Inc. | North Chicago, IL, United States | Packages it and labels it | No problems foundApr 27, 2026 · 19 inspections |
| AndersonBrecon Inc. | Rockford, IL, United States | Tests it, packages it and labels it | No problems foundAug 19, 2026 · 11 inspections |
| Pace Analytical Life Sciences, LLC | Morrisville, NC, United States | Tests it | No problems foundJul 10, 2026 · 1 inspection |
Product details
- Generic drug
- Dexlansoprazole: every company that makes it
- Form
- capsule, delayed release
- Strength
- 30 mg
- Approval
- NDA AUTHORIZED GENERIC NDA022287
- On the market since
- Jan 1, 2022
- Package NDCs
24979-703-06- Official label
- DailyMed (National Library of Medicine), updated Aug 3, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?